Shilpa Medicare Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 4675.57 Crore) operating in Pharmaceuticals sector.
iStockPromoters held 53.8 per cent stake in the company as of June 30, 2020, while FIIs held 26.5 per cent, DIIs 0.5 per cent and public and others 19.4 per cent.
ICICI Securities has given add rating to Sanofi India with a target price of Rs 8838. The share price moved up by 2.43 per cent from its previous close of Rs 560.75. The stock’s last traded price is Rs 574.35 . Shilpa Medicare Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 4675.57 Crore) operating in Pharmaceuticals sector.
Shilpa Medicare Ltd. key Products/Revenue Segments include Bulk Drugs (Intermediates) which contributed Rs 501.81 Crore to Sales Value (62.26 % of Total Sales), Formulations which contributed Rs 191.15 Crore to Sales Value (23.71 % of Total Sales), Other Operating Revenue which contributed Rs 89.68 Crore to Sales Value (11.12 % of Total Sales), Export Incentives which contributed Rs 9.03 Crore to Sales Value (1.12 % of Total Sales), Power which contributed Rs 5.99 Crore to Sales Value (0.74 % of Total Sales), Traded Goods which contributed Rs 4.59 Crore to Sales Value (0.56 % of Total Sales) and Others which contributed Rs 3.72 Crore to Sales Value (0.46 % of Total Sales)for the year ending 31-Mar-2020.
Financials For the quarter ended 30-06-2020, the company reported a Consolidated sales of Rs 222.86 Crore, up 1.31 % from last quarter Sales of Rs 219.99 Crore and up 38.43 % from last year same quarter Sales of Rs 160.99 Crore. The Company reported net profit after tax of Rs 86.60 Crore in latest quarter.
Promoter/FII Holdings Promoters held 53.8 per cent stake in the company as of June 30, 2020, while FIIs held 26.5 per cent, DIIs 0.5 per cent and public and others 19.4 per cent.
iStock
Get Unlimited Access to The Economic Times
